In addition, in prostate cancer, a mechanism has been described as leading to a translocation of CXCR4 to the nucleus, where it remains functional, ultimately resulting in increased metastatic potential and limited prognosis [22]. This evidence concerns the gene CXCR4 and prostate cancer.